NO994757L - Fremgangsmåte for oral administrasjon av proteiner - Google Patents

Fremgangsmåte for oral administrasjon av proteiner

Info

Publication number: NO994757L
Authority: NO; Norway
Prior art keywords: proteins; oral administration; oral; administration
Prior art date: 1997-04-02

Application number

NO994757A

Other languages

English (en)

Other versions

NO994757D0 (no

Inventor

Nicholas A Peppas

Anthony M Lowman

Tsuneji Nagai

Mariko Morishita

Original Assignee

Purdue Research Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-02

Filing date

1999-09-30

Publication date

1999-11-29

1999-09-30 Application filed by Purdue Research Foundation filed Critical Purdue Research Foundation

1999-09-30 Publication of NO994757D0 publication Critical patent/NO994757D0/no

1999-11-29 Publication of NO994757L publication Critical patent/NO994757L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Immunology (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

NO994757A 1997-04-02 1999-09-30 Fremgangsmåte for oral administrasjon av proteiner NO994757L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4228097P	1997-04-02	1997-04-02
US6136797P	1997-10-08	1997-10-08
PCT/US1998/006563 WO1998043615A1 (en)	1997-04-02	1998-04-02	Method for oral delivery of proteins

Publications (2)

Publication Number	Publication Date
NO994757D0 NO994757D0 (no)	1999-09-30
NO994757L true NO994757L (no)	1999-11-29

Family

ID=26719055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO994757A NO994757L (no)	1997-04-02	1999-09-30	Fremgangsmåte for oral administrasjon av proteiner

Country Status (14)

Country	Link
EP (1)	EP0975328A1 (no)
JP (1)	JP2002512607A (no)
KR (1)	KR20010005952A (no)
CN (1)	CN1259045A (no)
AU (1)	AU727053B2 (no)
BR (1)	BR9808466A (no)
CA (1)	CA2285457A1 (no)
IL (1)	IL132176A0 (no)
NO (1)	NO994757L (no)
NZ (1)	NZ500075A (no)
PL (1)	PL335974A1 (no)
TR (1)	TR199903240T2 (no)
WO (1)	WO1998043615A1 (no)
YU (1)	YU49699A (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9006175B2 (en)	1999-06-29	2015-04-14	Mannkind Corporation	Potentiation of glucose elimination
DE10040592A1 (de) *	2000-08-15	2002-03-07	Aventis Res & Tech Gmbh & Co	Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
US6878384B2 (en)	2001-03-13	2005-04-12	Microvention, Inc.	Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
GB0206048D0 (en) *	2002-03-14	2002-04-24	Croda Int Plc	Use
ES2425392T3 (es)	2002-03-20	2013-10-15	Mannkind Corporation	Cartucho para un aparato de inhalación
ES2385934T3 (es)	2004-08-20	2012-08-03	Mannkind Corporation	Catálisis de la síntesis de dicetopiperazina.
HUE025151T2 (en)	2004-08-23	2016-01-28	Mannkind Corp	Diceto-piperazine salts for drug delivery
US8110212B2 (en)	2005-04-07	2012-02-07	Drexel University	Bioactive thermogelling polymer systems and methods of their use
US11744803B2 (en)	2005-07-29	2023-09-05	Stichting Groningen Centre for Drug Rese	PH-controlled pulsatile delivery system, methods for preparation and use thereof
AU2006275424B2 (en) *	2005-08-01	2013-01-10	Mannkind Corporation	Method of preserving the function of insulin-producing cells
US7799344B2 (en)	2005-09-14	2010-09-21	Mannkind Corporation	Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US8039431B2 (en)	2006-02-22	2011-10-18	Mannkind Corporation	Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
EP2389960B1 (en)	2006-06-15	2018-02-28	MicroVention, Inc.	Environmentally responsive hydrogel
BRPI0821070B1 (pt)	2007-12-21	2018-10-23	Microvention Inc	dispositivo para implantação e método para a preparação de um filamento de hidrogel para implantação em um animal
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
DK2293833T3 (en)	2008-06-13	2016-05-23	Mannkind Corp	DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
JP5479465B2 (ja)	2008-06-20	2014-04-23	マンカインドコーポレイション	吸入努力をリアルタイムにプロファイルする対話式機器および方法
TWI494123B (zh)	2008-08-11	2015-08-01	Mannkind Corp	超快起作用胰島素之用途
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en)	2009-03-11	2017-06-27	Mannkind Corporation	Apparatus, system and method for measuring resistance of an inhaler
DK2424775T3 (en)	2009-04-30	2016-05-23	Technip France	A method and system for sharing a mooring line
US8551528B2 (en)	2009-06-12	2013-10-08	Mannkind Corporation	Diketopiperazine microparticles with defined specific surface areas
HUP0900482A2 (en)	2009-08-03	2011-03-28	Cera Med Kft	Pharmaceutical formulation for oral administration
EP2480166B1 (en)	2009-09-24	2017-11-29	Microvention, Inc.	Injectable hydrogel filaments for biomedical uses
CA2777171C (en)	2009-10-26	2017-09-19	Microvention, Inc.	Embolization device constructed from expansile polymer
US9016147B2 (en)	2009-11-03	2015-04-28	Mannkind Corporation	Apparatus and method for simulating inhalation efforts
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
MY180552A (en)	2011-04-01	2020-12-02	Mannkind Corp	Blister package for pharmaceutical cartridges
WO2012145431A2 (en)	2011-04-18	2012-10-26	Microvention, Inc.	Embolic devices
WO2012174472A1 (en)	2011-06-17	2012-12-20	Mannkind Corporation	High capacity diketopiperazine microparticles
EP2776053A1 (en)	2011-10-24	2014-09-17	MannKind Corporation	Methods and compositions for treating pain
US9011884B2 (en)	2012-04-18	2015-04-21	Microvention, Inc.	Embolic devices
SG11201500218VA (en)	2012-07-12	2015-03-30	Mannkind Corp	Dry powder drug delivery systems and methods
US10159644B2 (en)	2012-10-26	2018-12-25	Mannkind Corporation	Inhalable vaccine compositions and methods
AU2014228415B2 (en)	2013-03-15	2018-08-09	Mannkind Corporation	Microcrystalline diketopiperazine compositions and methods
MX394255B (es)	2013-07-18	2025-03-24	Mannkind Corp	Composiciones farmaceuticas en polvo seco estables al calor y metodos
WO2015021044A1 (en) *	2013-08-05	2015-02-12	University Of Rochester	Compositions and methods for stimuli-responsive release of a therapeutic agent
EP3030294B1 (en)	2013-08-05	2020-10-07	MannKind Corporation	Insufflation apparatus
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
WO2015153996A1 (en)	2014-04-03	2015-10-08	Micro Vention, Inc.	Embolic devices
CN106456836B (zh)	2014-04-29	2019-12-06	微仙美国有限公司	包含活性剂的聚合物
WO2015167751A1 (en)	2014-04-29	2015-11-05	Microvention, Inc.	Polymers
US10561806B2 (en)	2014-10-02	2020-02-18	Mannkind Corporation	Mouthpiece cover for an inhaler
US10265405B2 (en)	2014-11-18	2019-04-23	Board Of Regents, The University Of Texas System	Polymers for delivery of factor VIII and/or factor IX
WO2016201250A1 (en)	2015-06-11	2016-12-15	Microvention, Inc.	Expansile device for implantation
WO2024130101A1 (en) *	2022-12-16	2024-06-20	Wake Forest University Health Sciences	Hydrogel compositions and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2976576A (en) *	1956-04-24	1961-03-28	Wichterle Otto	Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) *	1960-12-21	1965-11-30	Wichterle Otto	Cross-linked hydrophilic polymers and articles made therefrom
IT1050353B (it) *	1966-01-06	1981-03-10	Ceskoslovenska Akademie Ved	Supporti per sostanze biologigamente attive
US3607848A (en) *	1967-08-07	1971-09-21	Ceskoslovenska Akademie Ved	Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) *	1968-03-06	1975-05-20	Ceskoslovenska Akademie Ved	Hydrogel laminates and method of manufacturing thereof
US4071508A (en) *	1975-02-11	1978-01-31	Plastomedical Sciences, Inc.	Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (fr) *	1986-04-15	1988-09-16	Rhone Poulenc Chimie	Matiere seche hydratable en un gel aqueux contenant des particules de polymeres dispersees, procede pour sa preparation et son application en biologie

1998
- 1998-04-02 BR BR9808466-6A patent/BR9808466A/pt not_active IP Right Cessation
- 1998-04-02 NZ NZ500075A patent/NZ500075A/xx unknown
- 1998-04-02 KR KR1019997009029A patent/KR20010005952A/ko not_active Withdrawn
- 1998-04-02 YU YU49699A patent/YU49699A/sh unknown
- 1998-04-02 TR TR1999/03240T patent/TR199903240T2/xx unknown
- 1998-04-02 WO PCT/US1998/006563 patent/WO1998043615A1/en not_active Ceased
- 1998-04-02 AU AU68809/98A patent/AU727053B2/en not_active Ceased
- 1998-04-02 IL IL13217698A patent/IL132176A0/xx unknown
- 1998-04-02 EP EP98914454A patent/EP0975328A1/en not_active Withdrawn
- 1998-04-02 CA CA002285457A patent/CA2285457A1/en not_active Abandoned
- 1998-04-02 PL PL98335974A patent/PL335974A1/xx unknown
- 1998-04-02 JP JP54201598A patent/JP2002512607A/ja active Pending
- 1998-04-02 CN CN98805351A patent/CN1259045A/zh active Pending
1999
- 1999-09-30 NO NO994757A patent/NO994757L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ500075A (en)	2001-03-30
PL335974A1 (en)	2000-06-05
KR20010005952A (ko)	2001-01-15
BR9808466A (pt)	2001-08-07
NO994757D0 (no)	1999-09-30
CN1259045A (zh)	2000-07-05
IL132176A0 (en)	2001-03-19
WO1998043615A1 (en)	1998-10-08
EP0975328A1 (en)	2000-02-02
AU727053B2 (en)	2000-11-30
YU49699A (sh)	2002-12-10
CA2285457A1 (en)	1998-10-08
AU6880998A (en)	1998-10-22
TR199903240T2 (xx)	2000-05-22
JP2002512607A (ja)	2002-04-23

Publication	Publication Date	Title
NO994757L (no)	1999-11-29	Fremgangsmåte for oral administrasjon av proteiner
NO995134D0 (no)	1999-10-21	Forbedrede fremgangsmåter for fremstilling av aktivert protein C
NO986202L (no)	1999-02-15	FremgangsmÕte for fremstilling av rekombinant adÚnovirus
DE69615887D1 (de)	2001-11-22	Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
FI973733L (fi)	1999-03-20	Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
NO951630L (no)	1995-10-30	Fremgangsmåte for administrering av azithromycin
EE04277B1 (et)	2004-04-15	Taksoidide klassi kuuluvate derivaatide valmistamismeetod
DK0754061T3 (da)	2002-08-26	Ny oral farmaceutisk doseringsform
ZA969001B (en)	1997-06-17	Method compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FI963679L (fi)	1996-09-17	Stabiloitu koostumus peptidien antamiseksi suun kautta
EE04418B1 (et)	2005-02-15	Moksifloksatsiini farmatseutiline preparaat
KR970000228A (ko)	1997-01-21	S-에토돌락의 경구용 제제
NO995251D0 (no)	1999-10-27	FremgangsmÕte for administrering av haloterapi
NO986177D0 (no)	1998-12-29	FremgangsmÕte for fremstilling av terapeutisk DNA
EE04154B1 (et)	2003-10-15	Omeprasooli valmistamise meetod
DK0868911T3 (da)	2003-01-20	Rapamycinpræparater til oral indgivelse
FI973229L (fi)	1997-08-05	Uusi farmaseuttinen koostumus
FI974578L (fi)	1999-06-20	Menetelmä levosimendaanin antamiseksi
NO994049D0 (no)	1999-08-23	Metode for å fremstille farmasöytiske forbindelser
EE9900404A (et)	2000-04-17	Arüülaminotriasolopüridiinide valmistamise meetod
NO943480L (no)	1996-03-20	Fremgangsmåte for direktetilpasning av proteser
FI974235A0 (fi)	1997-11-14	Ny bestaemningsmetod
KR970000226A (ko)	1997-01-21	S-이부프로펜의 경구용 제형
KR970701559A (ko)	1997-04-12	펩타이드의 경구 투여를 위한 안정화된 조성물(stabilized composition for oral administration of peptides)
UA25519A (uk)	1998-12-25	Спосіб іhтракаротидhого введеhhя лікарських препаратів

Legal Events

Date	Code	Title	Description
2003-12-08	FC2A	Withdrawal, rejection or dismissal of laid open patent application